Quick answer: methylcobalamin is the active coenzyme form of B12 used directly in metabolism without conversion. Cyanocobalamin is a synthetic form that the body converts to active coenzymes (methylcobalamin and adenosylcobalamin) after absorption. For most people, both work. Methylcobalamin is preferred for people with MTHFR gene variants (approximately 40% of the UK population), older adults with declining conversion efficiency, and people wanting the form naturally found in animal foods. Cyanocobalamin is cheaper, more stable and has a longer evidence trail in clinical trials.
What the two forms actually are
Vitamin B12 exists in several molecular forms. The two most common in supplements:
- Cyanocobalamin: a synthetic form not found naturally in food in significant amounts. Stable, inexpensive to manufacture, and used as the standard form in most pharmaceutical B12 products and clinical trials. Must be converted by the body to methylcobalamin or adenosylcobalamin to be used in biochemical reactions.
- Methylcobalamin: one of the two biologically active coenzyme forms. Found in animal foods. Used directly in methylation reactions without conversion. Preferred by many practitioners for nerve-related applications because methylcobalamin is the form required for myelin synthesis.
- Adenosylcobalamin (hydroxocobalamin): the other active coenzyme form, used primarily in mitochondrial energy reactions. Less common in retail supplements but used clinically.
Absorption and conversion: what the evidence actually shows
The standard B12 absorption pathway involves intrinsic factor (IF) in the stomach binding to B12 for active uptake in the ileum — this handles doses up to approximately 1.5–2μg per sitting. At higher supplemental doses (50–1,000μg), approximately 1% is absorbed via passive diffusion independently of intrinsic factor — which is why high-dose oral supplementation can bypass pernicious anaemia (IF deficiency).
Cyanocobalamin bioavailability: A 1998 study in Scandinavian Journal of Gastroenterology found cyanocobalamin and hydroxocobalamin were absorbed equivalently via the IF pathway in healthy adults. Cyanocobalamin raises serum B12 levels reliably and is the form used in most of the long-term safety and efficacy trials.
Methylcobalamin retention: A 2013 study in Clinical Nutrition Research found methylcobalamin had higher tissue retention than cyanocobalamin at equivalent doses — suggesting it may be better stored in tissues after absorption. This has practical implications for neurological applications where sustained tissue levels matter.
Honest limit: head-to-head superiority trials in general populations are limited. Most clinical evidence was built on cyanocobalamin because it was developed first. The practical difference for general B12 adequacy in healthy adults is small. The difference becomes more meaningful in specific populations (see below).
The MTHFR factor: why it matters for up to 40% of people
MTHFR (methylenetetrahydrofolate reductase) is an enzyme involved in the methylation cycle. Variants in the MTHFR gene — particularly C677T and A1298C — reduce the efficiency of this enzyme. The C677T homozygous variant is present in approximately 10–15% of the UK population; heterozygous variants affect approximately 40%.
In people with reduced MTHFR function, the conversion of cyanocobalamin to methylcobalamin may be less efficient — meaning they may not fully utilise synthetic forms that require conversion. Methylcobalamin bypasses this conversion step because it is already in the active form. For people with confirmed MTHFR variants, methylcobalamin (and methylfolate rather than folic acid) is widely recommended by practitioners over synthetic forms requiring conversion.
You do not need genetic testing before supplementing B12 — but if you have been supplementing cyanocobalamin consistently and still experience fatigue, brain fog or nerve symptoms with confirmed adequate serum B12, MTHFR conversion issues are worth investigating.
Neurological applications: where methylcobalamin has a specific advantage
Methylcobalamin is required for the remethylation of homocysteine to methionine — a critical step for myelin synthesis (the protective coating of nerve fibres). This makes it the more relevant form for nerve-related B12 applications.
What research supports: A 2015 systematic review in Nutrients found methylcobalamin supplementation significantly improved nerve conduction velocity and reduced neuropathic pain in diabetic peripheral neuropathy patients across multiple trials. A 2000 study in Internal Medicine (Yaqub et al.) found high-dose methylcobalamin at 500μg three times daily significantly improved nerve conduction and clinical symptoms in peripheral neuropathy vs placebo. For neurological applications specifically, most clinical trials and practice guidelines favour methylcobalamin over cyanocobalamin.
Stability and shelf life
Cyanocobalamin is significantly more stable than methylcobalamin — it is less sensitive to light, heat and humidity. This is why it is the standard form in pharmaceutical injections, fortified foods and products with long shelf lives. Methylcobalamin degrades faster when exposed to light — quality methylcobalamin supplements use amber bottles or opaque packaging to minimise degradation. A poorly stored methylcobalamin supplement may deliver less active B12 than its label claims. For cyanocobalamin, this is much less of a concern.
UK deficiency risk: who needs to supplement
B12 is found almost exclusively in animal products. UK NDNS 2019 data estimates 6% of adults under 60 have low B12 status, rising to 20%+ in adults over 65. Vegans have near-universal B12 insufficiency without supplementation — UK Vegan Society and NHS both explicitly recommend supplementation. South Asian vegetarian diets may also be lower in B12 than mixed diets.
People on long-term metformin have significantly reduced ileal B12 absorption — up to 30% impairment. People on long-term proton pump inhibitors (omeprazole, lansoprazole) also have reduced B12 absorption. Both groups require monitoring and may need higher supplemental doses or injections.
Which form to choose
- General B12 adequacy, vegan/vegetarian maintenance, cost priority: cyanocobalamin is effective and well-evidenced. Dose: 250–1,000μg/day orally.
- MTHFR variant (confirmed or suspected), nerve support, preference for active forms: methylcobalamin. Same dose range.
- Pernicious anaemia or severe malabsorption: requires GP management — typically injectable hydroxocobalamin (NHS standard) or very high-dose oral B12 (1,000μg/day) to enable passive diffusion absorption.
- Neurological symptoms: methylcobalamin — specifically the form studied in peripheral neuropathy trials.
Our ZenBlend and BioBrain both include methylcobalamin. For a dedicated B12 supplement, check the Halal Vitamins UK collection for declared-dose, HPMC capsule, halal certified options.
Is methylcobalamin better than cyanocobalamin?
For most people, both work for maintaining B12 status. Methylcobalamin has specific advantages for: people with MTHFR gene variants (reduced conversion efficiency of synthetic forms); neurological applications (required for myelin synthesis; multiple neuropathy trials favour methylcobalamin); older adults with declining conversion efficiency; and people who prefer the form naturally found in food. Cyanocobalamin has advantages for: stability (significantly more shelf-stable); cost (substantially cheaper); and the breadth of clinical trial evidence (most B12 trials used cyanocobalamin). The practical difference for general B12 adequacy in healthy adults is small.
What dose of B12 should I take daily?
The UK RNI for B12 is only 1.5μg/day from food, but supplement doses are much higher because absorption efficiency from supplements is lower than from food-bound B12 and decreases at higher doses. For vegans and vegetarians: 250–1,000μg cyanocobalamin or methylcobalamin daily is the standard recommendation (UK Vegan Society recommends at least 10μg/day or 2,000μg weekly). For diagnosed B12 deficiency not managed by injection: 1,000μg/day orally — passive diffusion at this dose bypasses intrinsic factor dependence. High-dose B12 supplementation has no established upper safe limit — excess is excreted in urine and no toxicity has been demonstrated at oral doses.
Can I take B12 with other supplements?
Yes — B12 has no meaningful interactions with other common supplements. It is a water-soluble vitamin that does not compete with other nutrients for absorption in the way minerals do. B12 works synergistically with folate (B9) and B6 in the homocysteine metabolism pathway — taking a B-complex that includes all three is often recommended for homocysteine management. If you take metformin or proton pump inhibitors (omeprazole, lansoprazole) long-term, have your B12 levels checked annually — both drugs impair B12 absorption and you may need higher doses than standard.
How long does it take for B12 supplements to work?
If your symptoms are driven by B12 deficiency, neurological improvements (energy, nerve function, cognition) are typically noticeable within 4–8 weeks of consistent daily supplementation at adequate doses. Serum B12 levels rise faster — measurable increases are typically seen within 2–4 weeks. For severe or longstanding deficiency with neurological involvement, full recovery may take several months and is not always complete. If fatigue or neurological symptoms do not improve after 8–12 weeks of adequate B12 supplementation, investigate other causes — iron, vitamin D, folate, thyroid function and other conditions all present with similar symptoms.